RenovoRx Inc.

NASDAQ: RNXT · Real-Time Price · USD
1.06
0.01 (0.95%)
At close: May 15, 2025, 10:08 AM

RenovoRx Revenue Breakdown

Period Ending Dec 31, 2024
Other Operating Segment Revenue 43K
Other Operating Segment Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 1.1M 1.18M 1.49M 1.22M 1M 1.35M 1.45M 1.92M 1.39M 1.31M 1.22M 1.72M 1.25M 628K 330K 418K 187K 183K 200K 248K
Selling, General, and Administrative Revenue Growth -6.71% -21.05% +22.40% +21.66% -26.00% -6.62% -24.60% +37.95% +6.01% +7.43% -28.67% +36.73% +99.84% +90.30% -21.05% +123.53% +2.19% -8.50% -19.35% n/a
Research and Development Revenue 1.58M 1.65M 1.54M 1.26M 775K 1.63M 1.93M 1.34M 776K 846K 1.39M 1.29M 1.1M 767K 536K 635K 452K 727K 402K 805K
Research and Development Revenue Growth -4.48% +7.00% +22.67% +62.19% -52.42% -15.38% +43.87% +72.42% -8.27% -39.14% +7.84% +17.08% +43.55% +43.10% -15.59% +40.49% -37.83% +80.85% -50.06% n/a